Kineret Related Clinical Trials
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis [Terminated]
Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease [Recruiting]
Anakinra or Denosumab and Everolimus in Advanced Cancer [Recruiting]
The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria [Completed]
Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA) [Completed]
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients [Recruiting]
Anakinra to Prevent Adverse Post-infarction Remodeling (2) [Completed]
Anakinra as a Treatment for Hydradenitis Suppurativa [Completed]
Kineret CAPS Post Authorisation Study [Recruiting]
Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma [Not yet recruiting]
Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis [Recruiting]
A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease [Completed]
Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss [Enrolling by invitation]
Anakinra and Kawasaki Disease [Not yet recruiting]
Anakinra to Prevent Post-infarction Remodeling [Completed]
Anakinra in Hidradenitis Suppurativa [Completed]
Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes [Completed]
Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3) [Recruiting]
AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIR TRIP) [Recruiting]
Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma [Completed]
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction [Completed]
Evaluating Kineret� (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire [Completed]
Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes [Recruiting]
A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy [Active, not recruiting]
Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis [Recruiting]
Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection [Not yet recruiting]
Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study [Recruiting]
Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus [Recruiting]
Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study [Active, not recruiting]
Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer [Recruiting]
Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease [Completed]
REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations [Completed]
Anakinra for Behcet s Disease [Completed]
Interleukin-1 Receptor Antagonist and Insulin Sensitivity [Active, not recruiting]
Anakinra for Inflammatory Pustular Skin Diseases [Recruiting]
Cytokine Inhibition in Chronic Fatigue Syndrome Patients [Recruiting]
Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA) [Completed]
Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study [Completed]
Treatment for Patients With Osteoarthritis (OA) of the Knee [Completed]
Interleukin-1 Blockade in Recently Decompensated Heart Failure [Recruiting]
Ineterleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF) [Recruiting]
Anti-Interleukin-1 in Diabetes Action [Completed]
Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain [Recruiting]
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure [Completed]
Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome [Completed]
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension [Terminated]
Juvenile Rheumatoid Arthritis [Completed]
Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy [Active, not recruiting]
Cyanobacteria Allergy in Lake Kineret [Not yet recruiting]
A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study [Recruiting]
Anakinra in Myositis [Completed]
Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS [Completed]
Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene [Completed]
Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis [Active, not recruiting]
The SPECTRA Study [Terminated]
Interleukin-1 Blockade in HF With Preserved EF [Recruiting]
Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients [Completed]
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease [Terminated]
IL-1RA, Acute Exercise, and Beta-cell Function [Recruiting]
Study to Prevent Cartilage Damage Following Acute Knee Injury. [Completed]
Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers [Completed]
Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis [Completed]
Anti-IL-1 Treatment in Children DKA at Diagnosis of Type 1 Diabetes [Recruiting]
Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2 [Recruiting]
Topical IL-1-Ra for Treatment of Posterior Blepharitis [Completed]
Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA) [Active, not recruiting]
Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation [Completed]
Real-Time Continuous Glucose Monitoring in Pre-School Children With Type-1 Diabetes Mellitus [Recruiting]
Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors [Recruiting]
Treatment for Patients With Osteoarthritis (OA) [Completed]
Rilonacept (Arcalyst �) in the Treatment of Subacromial Bursitis [Completed]
Ilaris (Canakinumab) in the Schnitzler Syndrome [Completed]
Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy [Recruiting]
Tocilizumab for Relapsing Polychondritis [Withdrawn]
Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease [Terminated]
Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease [Recruiting]
|